Interview with the CEO: EndoChoice Holdings, Inc. (NYSE:GI)

Healthcare >> CEO Interviews >> March 11, 2016

Mark Gilreath founded EndoChoice Holdings, Inc. in 2008 and serves as its CEO. Under his leadership, the company has been recognized five consecutive years by Inc. as one of the fastest-growing companies in America. Mr. Gilreath led the company to its IPO on the New York Stock Exchange in June 2015. Prior to EndoChoice Holdings, Inc., Mr. Gilreath served at Given Imaging as President of the Americas and Chief Marketing Officer. During his eight years at Given Imaging, the company launched the PillCam video capsule and was transformed from a pre-revenue startup to a NASDAQ company exceeding $100 million in revenue. Prior to joining Given Imaging, Mr. Gilreath served in a variety of management roles at PENTAX Medical during seven years of rapid growth. He began his career serving in the U.S. military in Naval Intelligence during Operation Desert Storm. Mr. Gilreath currently serves on the board of directors of EndoChoice Holdings, Inc., the Metro Atlanta Chamber of Commerce and the Medical Device Manufacturers Association. In 2013, Mr. Gilreath was selected as Business Person of the Year in Metro Atlanta. Mr. Gilreath holds a B.Sc. in finance from Winthrop University and an MBA from the Fuqua School of Business at Duke University. Profile

TWST: Can you provide a brief overview of the company and talk about what you perceive to be its value proposition right now?

Mr. Gilreath: EndoChoice is a GI

Join for free to read a longer excerpt or purchase this article

Interview with the CEO: EndoChoice Holdings, Inc. (NYSE:GI)

Top Company Interviews

CEO INTERVIEWS

SECTOR ROUNDTABLES

MONEY MANAGER INTERVIEWS

ANALYST INTERVIEWS

Interview with the CEO: EndoChoice Holdings, Inc. (NYSE:GI)

Top Company Interviews

Register for a Free Account to gain greater access to The Wall Street Transcript right now

CEO INTERVIEWS

SECTOR ROUNDTABLES

MONEY MANAGER INTERVIEWS

ANALYST INTERVIEWS